Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (23)
Shion A. Lim, Nicholas J. Agard, Ryan L. Kelly, Benjamin N. Bell, Si-Jie Chen, Anna M. Gram, J. Robert MerrittIan MoenchKatarina PanceTatjana Petojevic. 2023. 2023 Medicinal Chemistry Reviews. 2023 Medicinal Chemistry Reviews
713
798
.
Joana R. Dantas, Debora Batista Araujo, Karina Ribeiro Silva, Debora Lopes Souto, Maria de Fatima Carvalho Pereira, Luiz Ronir Raggio, Cesar Claudio-da Silva, Carlos Eduardo Couri, Angelo Maiolino, Carmen Lucia Kuniyoshi Rebellato, Debora Regina Daga, Alexandra Cristina Senegaglia, Paulo Roberto Slud Brofman, Leandra S. Baptista, Jose Egidio Paulo de Oliveira, Lenita Zajdenverg & Melanie Rodacki. (2023) Adipose Tissue-Derived Stromal/Stem Cells Transplantation
with Cholecalciferol Supplementation in Recent-Onset Type 1 Diabetes Patients:
Twelve Months Follow-Up. Hormone and Metabolic Research 55:08, pages 536-545.
Crossref
Crossref
Saurav Misra & Ajay Kumar Shukla. (2023) Teplizumab: type 1 diabetes mellitus preventable?. European Journal of Clinical Pharmacology 79:5, pages 609-616.
Crossref
Crossref
Jason Seewoodhary & Angela Silveira. (2023) Teplizumab – preventative approaches to type 1 diabetes mellitus. Practical Diabetes 40:2, pages 35.
Crossref
Crossref
C. C. Lachaud, N. Cobo-Vuilleumier, E. Fuente-Martin, I. Diaz, E. Andreu, G. M. Cahuana, J. R. Tejedo, A. Hmadcha, B. R. Gauthier & B. Soria. (2023) Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Nisha Karwal, Megan Rodrigues, David D. Williams, Ryan J. McDonough & Diana Ferro. (2021) Recent Advances of Integrative Bio-Omics Technologies to Improve Type 1 Diabetes (T1D) Care. Applied Sciences 11:24, pages 11602.
Crossref
Crossref
Sean Robinson & Ranjeny Thomas. (2021) Potential for Antigen-Specific Tolerizing Immunotherapy in Systematic Lupus Erythematosus. Frontiers in Immunology 12.
Crossref
Crossref
Debora B. Araujo, Joana R. Dantas, Karina R. Silva, Débora L. Souto, Maria de Fátima C. Pereira, Jessica P. Moreira, Ronir R. Luiz, Cesar S. Claudio-Da-Silva, Monica A. L. Gabbay, Sergio A. Dib, Carlos E. B. Couri, Angelo Maiolino, Carmen L. K. Rebelatto, Debora R. Daga, Alexandra C. Senegaglia, Paulo R. S. Brofman, Leandra Santos Baptista, José E. P. Oliveira, Lenita Zajdenverg & Melanie Rodacki. (2020) Allogenic Adipose Tissue-Derived Stromal/Stem Cells and Vitamin D Supplementation in Patients With Recent-Onset Type 1 Diabetes Mellitus: A 3-Month Follow-Up Pilot Study. Frontiers in Immunology 11.
Crossref
Crossref
Wensheng Mi, Yan Xia & Yanhui Bian. (2019) The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysis. Inflammation Research 68:4, pages 275-284.
Crossref
Crossref
Andrew D. Vonberg, Maria Acevedo-Calado, Aaron R. Cox, Susan L. Pietropaolo, Roberto Gianani, Steven K. Lundy & Massimo Pietropaolo. (2018) CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus. JCI Insight 3:23.
Crossref
Crossref
Jennifer J. Couper, Michael J. Haller, Carla J. Greenbaum, Anette-Gabriele Ziegler, Diane K. Wherrett, Mikael Knip & Maria E. Craig. (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents. Pediatric Diabetes 19, pages 20-27.
Crossref
Crossref
Y Ilan, K Shailubhai & A Sanyal. (2018) Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH. Clinical and Experimental Immunology 193:3, pages 275-283.
Crossref
Crossref
Charles J. Kroger, Matthew Clark, Qi Ke & Roland M. Tisch. (2018) Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes. Frontiers in Immunology 9.
Crossref
Crossref
Nadia Cobo-Vuilleumier, Petra I. Lorenzo, Noelia García Rodríguez, Irene de Gracia Herrera Gómez, Esther Fuente-Martin, Livia López-Noriega, José Manuel Mellado-Gil, Silvana-Yanina Romero-Zerbo, Mathurin Baquié, Christian Claude Lachaud, Katja Stifter, German Perdomo, Marco Bugliani, Vincenzo De Tata, Domenico Bosco, Geraldine Parnaud, David Pozo, Abdelkrim Hmadcha, Javier P. Florido, Miguel G. Toscano, Peter de Haan, Kristina Schoonjans, Luis Sánchez Palazón, Piero Marchetti, Reinhold Schirmbeck, Alejandro Martín-Montalvo, Paolo Meda, Bernat Soria, Francisco-Javier Bermúdez-Silva, Luc St-Onge & Benoit R. Gauthier. (2018) LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus. Nature Communications 9:1.
Crossref
Crossref
Mark A. Wallet, Katherine E. Santostefano, Naohiro Terada & Todd M. Brusko. (2017) Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes. Frontiers in Endocrinology 8.
Crossref
Crossref
S. Alice Long, Jerill Thorpe, Kevan C. Herold, Mario Ehlers, Srinath Sanda, Noha Lim, Peter S. Linsley, Gerald T. Nepom & Kristina M. Harris. (2017) Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes. Cellular Immunology 319, pages 3-9.
Crossref
Crossref
Giada Mondanelli, Elisa Albini, Maria T. Pallotta, Claudia Volpi, Lucienne Chatenoud, Chantal Kuhn, Francesca Fallarino, Davide Matino, Maria L. Belladonna, Roberta Bianchi, Carmine Vacca, Silvio Bicciato, Louis Boon, Giovanni Ricci, Ursula Grohmann, Paolo Puccetti & Ciriana Orabona. (2017) The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. Frontiers in Immunology 8.
Crossref
Crossref
Yun Zhang, Reza B. Jalili, Ruhangiz T. Kilani, Sanam Salimi Elizei, Ali Farrokhi, Mohsen Khosravi-Maharlooei, Garth L. Warnock, Ziliang Ao, Lucy Marzban & Aziz Ghahary. (2016) IDO-Expressing Fibroblasts Protect Islet Beta Cells From Immunological Attack and Reverse Hyperglycemia in Non-Obese Diabetic Mice. Journal of Cellular Physiology 231:9, pages 1964-1973.
Crossref
Crossref
Ningwen Tai, F. Susan Wong & Li Wen. (2016) The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes. Journal of Autoimmunity 71, pages 26-34.
Crossref
Crossref
Allyson Spence, Joanna E Klementowicz, Jeffrey A Bluestone & Qizhi Tang. (2015) Targeting Treg signaling for the treatment of autoimmune diseases. Current Opinion in Immunology 37, pages 11-20.
Crossref
Crossref
Dimeng Pang, Katharine M Irvine, Ahmed M Mehdi, Helen E Thomas, Mark Harris, Emma E Hamilton-Williams & Ranjeny Thomas. (2015) Expression profiling pre-diabetic mice to uncover drugs with clinical application to type 1 diabetes. Clinical & Translational Immunology 4:8, pages e41.
Crossref
Crossref
Jennifer J Couper, Michael J Haller, Annette-G Ziegler, Mikael Knip, Johnny Ludvigsson & Maria E Craig. (2014) Phases of type 1 diabetes in children and adolescents. Pediatric Diabetes 15:S20, pages 18-25.
Crossref
Crossref
Phuoc Thi-My Nguyen, Anh Thai-Quynh Nguyen, Nhung Thi Nguyen, Nguyet Thi-Minh Nguyen, Thu Thi Duong, Nhung Hai Truong & Ngoc Kim Phan. (2014) Human umbilical cord blood derived mesenchymal stem cells were differentiated into pancreatic endocrine cell by Pdx-1 electrotransfer. Biomedical Research and Therapy 1:2.
Crossref
Crossref